Anker SD, Koehler F, Abraham WT Telemedicine and remote management of patients with heart failure. Lancet. 2011 Aug 20;378(9792):731-9. doi: 10.1016/S0140-6736(11)61229-4.
Braun V, Heintze C, Rufer V, Welke J, Stein T, Mehrhof F, Dini L Innovative strategy for implementing chronic heart failure guidelines among family physicians in different healthcare settings in Berlin. Eur J Heart Fail. 2011 Jan;13(1):93-9. doi: 10.1093/eurjhf/hfq181. Epub 2010 Oct 14.
Doniec K, Dall'Alba R, King L Austerity threatens universal health coverage in Brazil. Lancet. 2016 Aug 27;388(10047):867-8. doi: 10.1016/S0140-6736(16)31428-3. Epub 2016 Aug 25. No abstract available.
Justino AL, Oliver LL, Melo TP Implementation of the Residency Program in Family and Community Medicine of the Rio de Janeiro Municipal Health Department, Brazil. Cien Saude Colet. 2016 May;21(5):1471-80. doi: 10.1590/1413-81232015215.04342016. English, Portuguese.
Laursen DH, Frolich A, Christensen U Patients' perception of disease and experience with type 2 diabetes patient education in Denmark. Scand J Caring Sci. 2017 Dec;31(4):1039-1047. doi: 10.1111/scs.12429. Epub 2017 May 12.
Niederseer D, Thaler CW, Niederseer M, Niebauer J Mismatch between heart failure patients in clinical trials and the real world. Int J Cardiol. 2013 Oct 3;168(3):1859-65. doi: 10.1016/j.ijcard.2012.12.069. Epub 2013 Jan 25.
Paim J, Travassos C, Almeida C, Bahia L, Macinko J The Brazilian health system: history, advances, and challenges. Lancet. 2011 May 21;377(9779):1778-97. doi: 10.1016/S0140-6736(11)60054-8. Epub 2011 May 9.
Soranz D, Pinto LF, Penna GO Themes and Reform of Primary Health Care (RCAPS) in the city of Rio de Janeiro, Brazil. Cien Saude Colet. 2016 May;21(5):1327-38. doi: 10.1590/1413-81232015215.01022016. English, Portuguese.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.